MODB | ZFIN | Morpholino Index | Advance Search | BLAST Search | About MODB
Search By For Use * as a wildcard character (e.g. "BMP*"). For Tips on search see Search FAQs.
Morpholino Summary
General Information
Morpholino name: SP1992 B    
Morpholino sequence: CTGTTTCTTTCCCAGTCGCTGAGGC
Find in Genbank
Target name: hs6st2
Target sequence: (Morpholino Target and ATG)
Search in Genbank Search in Ensembl
TGAGCCTCAGCGACTGGGAAAGAAACAGTCATGGCGGGGGAGGTGTATCTGCTTTGGTTGCTGCCGTTA TTACAGGGGTTGGCGTCGTATGGAGCAGAGCTCTCATCTGAGGCTTGCAGGGAGCTGGGGTTCTCCAGCA ATCTCCTGTGTAGCTCCTGTGAGCTTCTGGGTCAGTTCAGTCTGAACCAGCTAGACCTTCCCTGCAGGCA GTGCTGCCAAGAGGAGGCTCAGCTGGAGAACAGGAAGCTCTACCCAGGAGCCATCCTTGAGGTCTGTGGA TGAAAACTGGGGAGGTTCCCTCAAGTCCAAGCTTTTGTCAGGAGTGACAAGCCAAAGTTGTTCAGAGGGC TTCAAATCAAGTATGTGAGAGGCTCAGACCCTGTACTAAAGCTGTTGGACGATAACGGGAACATCGCTGA AGAGCTCAGCATCCTCAAGTGGAACACAGACAGCGTTGAAGAATTTCTTAGTGAGAAGTTAGAGCGAATT TAAACGCAGTTTCATAGTCAAAATCCAATTTTCACGTTTTTTTTTATTATGTCAATCAAGCCGATTTAAA GGACCACGCTTCATAAAAATCATTCTTCCGTTTGGTTTGGGAATATCTGTACTAAATTTGGTTTATTTCT ATGCTACGTGTATTTGTATTGTTGATTGTTGCTGAGGGGCTTTTTATACCTCTTGTTGTTTGAGTAAACT GTGTGAAGCTTGTTGAATATGCTGGATTGATGAAGCTTGTGGCGGGGACTCAGAAACACACGCTTGTGTA GATTTGCACTTTAGTGAAGGCCTGACTGTAAACCACTCTATGGCATGTCAGGCCTGAAGATCCTGTGTAC GTCTCTCAGCGTGTTGTTTTTGGGGAAACGTTCAAGCTTTACCACAGTGTGAGACAATTTCATTAGTGCG CACAAACACAAATAAACCTGTTTTTCATATGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Gene targeted:
heparan sulfate 6-O-sulfotransferase 2
Find in ZFIN Find in Pubmed
All the morpholinos targets to the gene
Synonyms:
Comments:
Reference:

Survival Curve: Normality Curve:
Note: When more than one data point existed per dose an average was used. p53 morpholino co-injections were used to minimize non-specific toxicity effects (Robu et al. PLoS Genetics 2007)
Screens Performed (number of tests): Defects Observed:
Cranial Motor Neuron: (2)
Vasculature: (3)
Eye: (5)
Toxicity: (2)
Morphology: (1)
- eye absent
(10%, dose:3ng, p53:ng, days: Day: 3)
- cardiovascular system decreased
(16.67%, dose:6ng, p53:0ng, days: -)
- axis dysplastic
(16.67%, dose:6ng, p53:0ng, days: -)
- eye absent
(17.65%, dose:6ng, p53:ng, days: Day: 2)
- eye dysplastic
(11.76%, dose:6ng, p53:ng, days: Day: 2)
- cardiac ventricle large size
(20%, dose:7.5ng, p53:0ng, days: -)
- somite square
(10%, dose:7.5ng, p53:0ng, days: -)
- cranial nerve X decreased number
(20%, dose:7.5ng, p53:0ng, days: -)
- cranial nerve X mislocalised
(50%, dose:15ng, p53:0ng, days: -)
- cranial nerve VII mislocalised
(50%, dose:15ng, p53:0ng, days: -)
- cranial nerve V mislocalised
(50%, dose:15ng, p53:0ng, days: -)

Images